Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Dengler

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the ratB Sido, G Otto, R Zimmermann, et al.
European Heart Journal|December 14, 2001
Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosisR Kell, A Haunstetter, T J Dengler, et al.
Cellular Immunology|January 15, 1998
Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the ratB Sido, G Otto, R Zimmermann, et al.
European Journal of Immunology|May 16, 1998
Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody productionB Sido, T J Dengler, G Otto, et al.
Heart (British Cardiac Society)|May 16, 2002
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct sizeM Licka, R Zimmermann, J Zehelein, et al.
Histopathology|May 10, 2006
Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathyE Herpel, M Pritsch, A Koch, et al.
Transplantation Proceedings|June 1, 1995
Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantationT J Dengler, C P Tiefenbacher, K Braun, et al.
Transplantation Proceedings|May 22, 1998
Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantationT J Dengler, G Szabo, K Amann, et al.
Transplantation Proceedings|September 25, 2002
Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantationC A Gleissner, J Zehelein, F U Sack, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 1998
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejectionS Bährle, G Szabó, A Stiehl, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the ratB Sido, G Otto, R Zimmermann, et al.
European Heart Journal|December 14, 2001
Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosisR Kell, A Haunstetter, T J Dengler, et al.
Cellular Immunology|January 15, 1998
Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the ratB Sido, G Otto, R Zimmermann, et al.
European Journal of Immunology|May 16, 1998
Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody productionB Sido, T J Dengler, G Otto, et al.
Heart (British Cardiac Society)|May 16, 2002
Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct sizeM Licka, R Zimmermann, J Zehelein, et al.
Histopathology|May 10, 2006
Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathyE Herpel, M Pritsch, A Koch, et al.
Transplantation Proceedings|June 1, 1995
Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantationT J Dengler, C P Tiefenbacher, K Braun, et al.
Transplantation Proceedings|May 22, 1998
Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantationT J Dengler, G Szabo, K Amann, et al.
Transplantation Proceedings|September 25, 2002
Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantationC A Gleissner, J Zehelein, F U Sack, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 14, 1998
Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejectionS Bährle, G Szabó, A Stiehl, et al.
Pageof 6